-
1
-
-
33846457870
-
-
10.3322/canjclin.57.1.43, 17237035
-
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. CA Cancer J Clin 2007, 57(1):43-66. 10.3322/canjclin.57.1.43, 17237035.
-
(2007)
CA Cancer J Clin
, vol.57
, Issue.1
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Thun, M.J.6
-
2
-
-
77950814616
-
The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer
-
10.2174/138945010790980385, 20015012
-
Gallo D, Ferlini C, Scambia G. The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer. Curr Drug Targets 2010, 11(4):474-481. 10.2174/138945010790980385, 20015012.
-
(2010)
Curr Drug Targets
, vol.11
, Issue.4
, pp. 474-481
-
-
Gallo, D.1
Ferlini, C.2
Scambia, G.3
-
3
-
-
50649124650
-
Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha
-
10.1210/me.2007-0512, 18550773
-
Park SH, Cheung LW, Wong AS, Leung PC. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol Endocrinol 2008, 22(9):2085-2098. 10.1210/me.2007-0512, 18550773.
-
(2008)
Mol Endocrinol
, vol.22
, Issue.9
, pp. 2085-2098
-
-
Park, S.H.1
Cheung, L.W.2
Wong, A.S.3
Leung, P.C.4
-
4
-
-
0029740105
-
Nuclear receptor coactivators and corepressors
-
10.1210/me.10.10.1167, 9121485
-
Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol 1996, 10(10):1167-1177. 10.1210/me.10.10.1167, 9121485.
-
(1996)
Mol Endocrinol
, vol.10
, Issue.10
, pp. 1167-1177
-
-
Horwitz, K.B.1
Jackson, T.A.2
Bain, D.L.3
Richer, J.K.4
Takimoto, G.S.5
Tung, L.6
-
5
-
-
34250881447
-
Coregulators: from whence came these "master genes"
-
10.1210/me.2007-0012, 17284664
-
O'Malley BW. Coregulators: from whence came these "master genes". Mol Endocrinol 2007, 21(5):1009-1013. 10.1210/me.2007-0012, 17284664.
-
(2007)
Mol Endocrinol
, vol.21
, Issue.5
, pp. 1009-1013
-
-
O'Malley, B.W.1
-
6
-
-
79958746301
-
Regulation of rDNA transcription by proto-oncogene PELP1
-
10.1371/journal.pone.0021095, 3113909, 21695158
-
Gonugunta VK, Nair BC, Rajhans R, Sareddy GR, Nair SS, Vadlamudi RK. Regulation of rDNA transcription by proto-oncogene PELP1. PLoS One 2011, 6(6):e21095. 10.1371/journal.pone.0021095, 3113909, 21695158.
-
(2011)
PLoS One
, vol.6
, Issue.6
-
-
Gonugunta, V.K.1
Nair, B.C.2
Rajhans, R.3
Sareddy, G.R.4
Nair, S.S.5
Vadlamudi, R.K.6
-
7
-
-
34250619620
-
Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR
-
1876599, 17525794
-
Vadlamudi RK, Kumar R. Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR. Nucl Recept Signal 2007, 5:e004. 1876599, 17525794.
-
(2007)
Nucl Recept Signal
, vol.5
-
-
Vadlamudi, R.K.1
Kumar, R.2
-
8
-
-
0037069418
-
Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade
-
10.1073/pnas.192569699, 137496, 12415108
-
Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade. Proc Natl Acad Sci U S A 2002, 99(23):14783-14788. 10.1073/pnas.192569699, 137496, 12415108.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, Issue.23
, pp. 14783-14788
-
-
Wong, C.W.1
McNally, C.2
Nickbarg, E.3
Komm, B.S.4
Cheskis, B.J.5
-
9
-
-
10344251495
-
Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors
-
10.1210/jc.2004-0909, 1262662, 15579769
-
Vadlamudi RK, Balasenthil S, Broaddus RR, Gustafsson JA, Kumar R. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors. J Clin Endocrinol Metab 2004, 89(12):6130-6138. 10.1210/jc.2004-0909, 1262662, 15579769.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, Issue.12
, pp. 6130-6138
-
-
Vadlamudi, R.K.1
Balasenthil, S.2
Broaddus, R.R.3
Gustafsson, J.A.4
Kumar, R.5
-
10
-
-
77952823885
-
Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells
-
10.1158/0008-5472.CAN-09-3834, 2889925, 20460518
-
Chakravarty D, Nair SS, Santhamma B, Nair BC, Wang L, Bandyopadhyay A, Agyin JK, Brann D, Sun LZ, Yeh IT. Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells. Cancer Res 2010, 70(10):4092-4101. 10.1158/0008-5472.CAN-09-3834, 2889925, 20460518.
-
(2010)
Cancer Res
, vol.70
, Issue.10
, pp. 4092-4101
-
-
Chakravarty, D.1
Nair, S.S.2
Santhamma, B.3
Nair, B.C.4
Wang, L.5
Bandyopadhyay, A.6
Agyin, J.K.7
Brann, D.8
Sun, L.Z.9
Yeh, I.T.10
-
11
-
-
77950858916
-
The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype
-
10.1007/s10549-009-0419-9, 19495959
-
Habashy HO, Powe DG, Rakha EA, Ball G, Macmillan RD, Green AR, Ellis IO. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype. Breast Cancer Res Treat 2010, 120(3):603-612. 10.1007/s10549-009-0419-9, 19495959.
-
(2010)
Breast Cancer Res Treat
, vol.120
, Issue.3
, pp. 603-612
-
-
Habashy, H.O.1
Powe, D.G.2
Rakha, E.A.3
Ball, G.4
Macmillan, R.D.5
Green, A.R.6
Ellis, I.O.7
-
12
-
-
79954624183
-
Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis
-
10.1158/1078-0432.CCR-10-2718, 21421858
-
Chakravarty D, Roy SS, Babu CR, Dandamudi R, Curiel TJ, Vivas-Mejia P, Lopez-Berestein G, Sood AK, Vadlamudi RK. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis. Clin Cancer Res 2011, 17(8):2250-2259. 10.1158/1078-0432.CCR-10-2718, 21421858.
-
(2011)
Clin Cancer Res
, vol.17
, Issue.8
, pp. 2250-2259
-
-
Chakravarty, D.1
Roy, S.S.2
Babu, C.R.3
Dandamudi, R.4
Curiel, T.J.5
Vivas-Mejia, P.6
Lopez-Berestein, G.7
Sood, A.K.8
Vadlamudi, R.K.9
-
13
-
-
49649094092
-
Role of PELP1/MNAR signaling in ovarian tumorigenesis
-
10.1158/0008-5472.CAN-07-5698, 18559538
-
Dimple C, Nair SS, Rajhans R, Pitcheswara PR, Liu J, Balasenthil S, Le XF, Burow ME, Auersperg N, Tekmal RR. Role of PELP1/MNAR signaling in ovarian tumorigenesis. Cancer Res 2008, 68(12):4902-4909. 10.1158/0008-5472.CAN-07-5698, 18559538.
-
(2008)
Cancer Res
, vol.68
, Issue.12
, pp. 4902-4909
-
-
Dimple, C.1
Nair, S.S.2
Rajhans, R.3
Pitcheswara, P.R.4
Liu, J.5
Balasenthil, S.6
Le, X.F.7
Burow, M.E.8
Auersperg, N.9
Tekmal, R.R.10
-
14
-
-
38449084929
-
Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study
-
Hogdall EV, Christensen L, Hogdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study. Oncol Rep 2007, 18(5):1051-1059.
-
(2007)
Oncol Rep
, vol.18
, Issue.5
, pp. 1051-1059
-
-
Hogdall, E.V.1
Christensen, L.2
Hogdall, C.K.3
Blaakaer, J.4
Gayther, S.5
Jacobs, I.J.6
Christensen, I.J.7
Kjaer, S.K.8
-
15
-
-
77950629251
-
Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary
-
10.1007/s00404-009-1185-y, 19639330
-
Burges A, Bruning A, Dannenmann C, Blankenstein T, Jeschke U, Shabani N, Friese K, Mylonas I. Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary. Arch Gynecol Obstet 2010, 281(3):511-517. 10.1007/s00404-009-1185-y, 19639330.
-
(2010)
Arch Gynecol Obstet
, vol.281
, Issue.3
, pp. 511-517
-
-
Burges, A.1
Bruning, A.2
Dannenmann, C.3
Blankenstein, T.4
Jeschke, U.5
Shabani, N.6
Friese, K.7
Mylonas, I.8
-
16
-
-
67651149472
-
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors
-
10.1016/j.ygyno.2009.05.045, 2756056, 19560192
-
Arias-Pulido H, Smith HO, Joste NE, Bocklage T, Qualls CR, Chavez A, Prossnitz ER, Verschraegen CF. Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors. Gynecol Oncol 2009, 114(3):480-485. 10.1016/j.ygyno.2009.05.045, 2756056, 19560192.
-
(2009)
Gynecol Oncol
, vol.114
, Issue.3
, pp. 480-485
-
-
Arias-Pulido, H.1
Smith, H.O.2
Joste, N.E.3
Bocklage, T.4
Qualls, C.R.5
Chavez, A.6
Prossnitz, E.R.7
Verschraegen, C.F.8
-
17
-
-
13844299310
-
Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer
-
10.1016/j.ygyno.2004.11.010, 15721410
-
Lee P, Rosen DG, Zhu C, Silva EG, Liu J. Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer. Gynecol Oncol 2005, 96(3):671-677. 10.1016/j.ygyno.2004.11.010, 15721410.
-
(2005)
Gynecol Oncol
, vol.96
, Issue.3
, pp. 671-677
-
-
Lee, P.1
Rosen, D.G.2
Zhu, C.3
Silva, E.G.4
Liu, J.5
-
18
-
-
0034667743
-
Steroid hormone receptors and long term survival in invasive ovarian cancer
-
10.1002/1097-0142(20001015)89:8<1783::AID-CNCR19>3.0.CO;2-D, 11042574
-
Munstedt K, Steen J, Knauf AG, Buch T, von Georgi R, Franke FE. Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 2000, 89(8):1783-1791. 10.1002/1097-0142(20001015)89:8<1783::AID-CNCR19>3.0.CO;2-D, 11042574.
-
(2000)
Cancer
, vol.89
, Issue.8
, pp. 1783-1791
-
-
Munstedt, K.1
Steen, J.2
Knauf, A.G.3
Buch, T.4
von Georgi, R.5
Franke, F.E.6
-
19
-
-
0023340925
-
Stegner HE: [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]
-
Remmele W. Stegner HE: [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987, 8(3):138-140.
-
(1987)
Pathologe
, vol.8
, Issue.3
, pp. 138-140
-
-
Remmele, W.1
-
20
-
-
11244339719
-
Mucinous tumors of the ovary: a review
-
Hart WR. Mucinous tumors of the ovary: a review. Int J Gynecol Pathol 2005, 24(1):4-25.
-
(2005)
Int J Gynecol Pathol
, vol.24
, Issue.1
, pp. 4-25
-
-
Hart, W.R.1
-
21
-
-
66149083645
-
Shih Ie M: Ovarian cancer
-
10.1146/annurev.pathol.4.110807.092246, 2679364, 18842102
-
Cho KR. Shih Ie M: Ovarian cancer. Annu Rev Pathol 2009, 4:287-313. 10.1146/annurev.pathol.4.110807.092246, 2679364, 18842102.
-
(2009)
Annu Rev Pathol
, vol.4
, pp. 287-313
-
-
Cho, K.R.1
-
22
-
-
3042662331
-
Estrogen and progesterone receptors in ovarian epithelial tumors
-
Lindgren PR, Cajander S, Backstrom T, Gustafsson JA, Makela S, Olofsson JI. Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol 2004, 221(1-2):97-104.
-
(2004)
Mol Cell Endocrinol
, vol.221
, Issue.1-2
, pp. 97-104
-
-
Lindgren, P.R.1
Cajander, S.2
Backstrom, T.3
Gustafsson, J.A.4
Makela, S.5
Olofsson, J.I.6
-
23
-
-
80052713086
-
Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival
-
10.1007/s12253-010-9340-0, 3158974, 21207255
-
Halon A, Materna V, Drag-Zalesinska M, Nowak-Markwitz E, Gansukh T, Donizy P, Spaczynski M, Zabel M, Dietel M, Lage H. Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival. Pathol Oncol Res 2011, 17(3):511-518. 10.1007/s12253-010-9340-0, 3158974, 21207255.
-
(2011)
Pathol Oncol Res
, vol.17
, Issue.3
, pp. 511-518
-
-
Halon, A.1
Materna, V.2
Drag-Zalesinska, M.3
Nowak-Markwitz, E.4
Gansukh, T.5
Donizy, P.6
Spaczynski, M.7
Zabel, M.8
Dietel, M.9
Lage, H.10
-
24
-
-
67651030487
-
Expressions of estrogen and progesterone receptors in epithelial ovarian cancer: a clinicopathologic study
-
10.1111/IGC.0b013e3181a44b62, 19509560
-
Tangjitgamol S, Manusirivithaya S, Khunnarong J, Jesadapatarakul S, Tanwanich S. Expressions of estrogen and progesterone receptors in epithelial ovarian cancer: a clinicopathologic study. Int J Gynecol Cancer 2009, 19(4):620-627. 10.1111/IGC.0b013e3181a44b62, 19509560.
-
(2009)
Int J Gynecol Cancer
, vol.19
, Issue.4
, pp. 620-627
-
-
Tangjitgamol, S.1
Manusirivithaya, S.2
Khunnarong, J.3
Jesadapatarakul, S.4
Tanwanich, S.5
-
25
-
-
77951129233
-
PELP1: A novel therapeutic target for hormonal cancers
-
2997573, 20014005
-
Chakravarty D, Tekmal RR, Vadlamudi RK. PELP1: A novel therapeutic target for hormonal cancers. IUBMB Life 2010, 62(3):162-169. 2997573, 20014005.
-
(2010)
IUBMB Life
, vol.62
, Issue.3
, pp. 162-169
-
-
Chakravarty, D.1
Tekmal, R.R.2
Vadlamudi, R.K.3
-
26
-
-
84864913725
-
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
-
10.1186/bcr3229, 22812534
-
Cortez V, Mann M, Tekmal S, Suzuki T, Miyata N, Rodriguez-Aguayo C, Lopez-Berestein G, Sood AK, Vadlamudi RK. Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer. Breast Cancer Res 2012, 14(4):R108. 10.1186/bcr3229, 22812534.
-
(2012)
Breast Cancer Res
, vol.14
, Issue.4
-
-
Cortez, V.1
Mann, M.2
Tekmal, S.3
Suzuki, T.4
Miyata, N.5
Rodriguez-Aguayo, C.6
Lopez-Berestein, G.7
Sood, A.K.8
Vadlamudi, R.K.9
-
27
-
-
34347208713
-
Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor
-
10.1158/0008-5472.CAN-06-3647, 2774841, 17545633
-
Rajhans R, Nair S, Holden AH, Kumar R, Tekmal RR, Vadlamudi RK. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor. Cancer Res 2007, 67(11):5505-5512. 10.1158/0008-5472.CAN-06-3647, 2774841, 17545633.
-
(2007)
Cancer Res
, vol.67
, Issue.11
, pp. 5505-5512
-
-
Rajhans, R.1
Nair, S.2
Holden, A.H.3
Kumar, R.4
Tekmal, R.R.5
Vadlamudi, R.K.6
-
28
-
-
67650241992
-
Expression of ERalpha, ERbeta and co-regulator PELP1/MNAR in colorectal cancer: prognostic significance and clinicopathologic correlations
-
Grivas PD, Tzelepi V, Sotiropoulou-Bonikou G, Kefalopoulou Z, Papavassiliou AG, Kalofonos H. Expression of ERalpha, ERbeta and co-regulator PELP1/MNAR in colorectal cancer: prognostic significance and clinicopathologic correlations. Cell Oncol 2009, 31(3):235-247.
-
(2009)
Cell Oncol
, vol.31
, Issue.3
, pp. 235-247
-
-
Grivas, P.D.1
Tzelepi, V.2
Sotiropoulou-Bonikou, G.3
Kefalopoulou, Z.4
Papavassiliou, A.G.5
Kalofonos, H.6
|